CoChat

Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease

Rembach, Alan, Faux, Noel G., Watt, Andrew D., Pertile, Kelly K., Rumble, Rebecca L., Trounson, Brett O., Fowler, Christopher J., Roberts, Blaine R., Perez, Keyla A., Li, Qiao‐Xin, Laws, Simon M., Taddei, Kevin, Rainey‐Smith, Stephanie, Robertson, Joanne S., Vandijck, Manu, Vanderstichele, Hugo, Barnham, Kevin J., Ellis, Kathryn A., Szoeke, Cassandra, Macaulay, Lance, Rowe, Christopher C., Villemagne, Victor L., Ames, David, Martins, Ralph N., Bush, Ashley I., Masters, Colin L., AIBL research group · 2014 · Alzheimer's & Dementia
Cited by 134

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Background: A practical biomarker is required to facilitate the preclinical diagnosis of Alzheimer's disease (AD). Methods: Plasma amyloid beta (Aβ)1–40, Aβ 1–42, Aβ n–40, and Aβ n–42 peptides were measured at baseline and after 18 months in 771 participants from the Australian Imaging Biomarkers and Lifestyle (AIBL) study of aging. Aβ peptide levels were compared with clinical pathology, neuroimaging and neuropsychological measurements. Results: Although inflammatory and renal function covariates influenced plasma Aβ levels significantly, a decrease in Aβ 1–42/Aβ 1–40 was observed in patients with AD, and was also inversely correlated with neocortical amyloid burden. During the 18 months, plasma Aβ 1–42 decreased in subjects with mild cognitive impairment (MCI) and in those transitioning from healthy to MCI. Conclusion: Our findings are consistent with a number of published plasma Aβ studies and, although the prognostic value of individual measures in any given subject is limited, the diagnostic contribution of plasma Aβ may demonstrate utility when combined with a panel of peripheral biomarkers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2012.12.006

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 134

Metadata

Authors
Rembach, A., Faux, N. G., Watt, A. D., Pertile, K. K., Rumble, R. L., Trounson, B. O., Fowler, C. J., Roberts, B. R., Perez, K. A., Li, Q., Laws, S. M., Taddei, K., Rainey‐Smith, S., Robertson, J. S., Vandijck, M., Vanderstichele, H., Barnham, K. J., Ellis, K. A., Szoeke, C., Macaulay, L., Rowe, C. C., Villemagne, V. L., Ames, D., Martins, R. N., Bush, A. I., Masters, C. L., & AIBL research group
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2013-03-14
Volume
10
Issue
1
Pages
53-61
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W2117047219
Cited by
134
References
6
FWCI
6.59
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease. https://app.cochat.ai/papers/10.1016/j.jalz.2012.12.006
The paper
Rembach, A., Faux, N. G., Watt, A. D., Pertile, K. K., Rumble, R. L., Trounson, B. O., Fowler, C. J., Roberts, B. R., Perez, K. A., Li, Q., Laws, S. M., Taddei, K., Rainey‐Smith, S., Robertson, J. S., Vandijck, M., Vanderstichele, H., Barnham, K. J., Ellis, K. A., Szoeke, C., . . . AIBL research group. (2014). Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2012.12.006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.